in as many arms as possible and that was a huge logistical exercise. some sports stadiums opened their doors. second doses for some. thank you for coming in today. the jab will be the pfizerjab. ..while younger people were encouraged to get their firstjab. churches and cathedrals were also turned into vaccine hubs. but some concerns emerged about rare blood clots linked to the 0xford astrazeneca vaccine. fergus walsh: business as usual in northeast london. headlines about blood clots didn t put people off getting the astrazeneca vaccine. the thought of catching covid is more severe than having a blood clot. taking any medicine, there s always a side effect. so i wasn t really unduly concerned about having the jab. 79 rare blood clots have been identified out of 20 million doses
from our health reporter laura - from our health reporter laura foster. you havejust come from our health reporter laura foster. you have just come out of a briefing specifically about the new variant? in briefing specifically about the new variant? , , ., variant? in this briefing we got confirmation variant? in this briefing we got confirmation from variant? in this briefing we got confirmation from an - variant? in this briefing we got confirmation from an early - variant? in this briefing we got - confirmation from an early analysis that the vaccine is not protecting as well as we might have hoped against 0micron, but better than we feared. but the good news is that by having a booster you can really increase your protection. this analysis looked at pfizer, and oxford astrazeneca, what it found it 0xford astrazeneca, what it found it after analysing cases with 0micron and thousands of cases with delta, after looking at how effective the vaccines were against the new variant it
-year-olds. i look about that point in a moment. -year-olds. i look about that point in a moment, but -year-olds. i look about that point in a moment, but what -year-olds. i look about that point in a moment, but what can - -year-olds. i look about that point in a moment, but what can you - -year-olds. i look about that point l in a moment, but what can you tells about countries, information from countries where they have already been vaccinating this age group including about that condition, myocarditis, which you mentioned? well, it is actually pretty reassuring. it is like the rare blood clots that we saw with 0xford astrazeneca. the are very rare adverse events are for whatever reason they seem to occur, slightly more likely in males, and other links heart conditions in younger people, so there are case reports but, as i say, they are very small numbers. the israelis released something yesterday were comparative data overall showing that overall the risks of myocarditis and th
and austrian 0xford astrazeneca came at a german and british labs and i m very proud we are establishing a new herschel model for british women in your honour, just one of the lasting legacies of your leadership. it is great to welcome you here today, over to you, angela. welcome you here today, over to you, anuela. . ~ welcome you here today, over to you, anuela. ., ~ i. welcome you here today, over to you, anuela. . ~ , angela. thank you, prime minister, dear boris. angela. thank you, prime minister, dear boris, thank angela. thank you, prime minister, dear boris, thank you. angela. thank you, prime minister, dear boris, thank you. thank - angela. thank you, prime minister, dear boris, thank you. thank you i angela. thank you, prime minister, | dear boris, thank you. thank you for the very dear boris, thank you. thank you for the very warm words of welcome for this gracious hospitality, this is my first this gracious hospitality, this is my first bilateral visit abroad af
reassure their populations first, but i think that it is nevertheless very much in line with what europeans want to see in terms of the global vaccine campaign. richer nations to be sharing with the developing world. we have just launched this week, from vcfr a study of 12 eu member states, 70,000 people, we asked whether or not they thought their country should be sharing vaccines with poorer countries, the largest answer was that should happen immediately, the second largest answer was as soon as possible vulnerable population had been vaccinated. and that is the majority, those two responses, and that is where we re at now europe. these decisions need to be in line with where public opinion is on this. the 0xford astrazeneca model of providing vaccines is to do so on a not for profit basis during the pandemic. how successful might borisjohnson be in persuading other g7 leaders to get